DI BELLA FOUNDATION
>
DOCUMENTATION INDEX > SCIENTIFIC WORKS
Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
(06/05/2011)
Detail
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.
(06/05/2011)
Detail
Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells.
(06/05/2011)
Detail
Basic mechanisms involved in the anti-cancer effects of melatonin.
(06/05/2011)
Detail
Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.
(06/05/2011)
Detail
M elatonin, a promising role in taxane-related neuropathy.
(06/05/2011)
Detail
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
(06/05/2011)
Detail
Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.
(06/05/2011)
Detail
Melatonin and vitamin D(3) synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells.
(06/05/2011)
Detail
Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide-induced urinary bladder injury in rat.
(06/05/2011)
Detail
Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.
(06/05/2011)
Detail
Melatonin and metformin inhibit skin carcinogenesis induced by benz(a)pyrene in mice
(06/05/2011)
Detail
Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC.
(06/05/2011)
Detail
Melatonin: a multitasking molecule.
(06/05/2011)
Detail
Beneficial effects of melatonin on nicotine-induced vasculopathy.
(06/05/2011)
Detail